As of March 19, the stock had risen to $0.57. On March 20, it fell to $0.46. This reverses a recent surge that began after Salem announced its strategic buyback announcement in late-December, jumping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback